R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo Nordisk (NVO), Novartis (NVS), Pfizer (PFE) and Bayer (BAYRY) are worth re ...

R&D innovation is likely to ... The stock has lost 12.5% so far this year. Price and Consensus: NVO Bayer: The company’s key drugs, Nubeqa for cancer and Kerendia for chronic kidney disease ...

The Inflation Reduction Act was passed in 2021 to reduce the government deficit, incentivize domestic energy production, and ...

In this week’s edition of InnovationRx, we look at the trend in fatal drug overdoses, 23andMe’s bankruptcy, the new CDC ...

Season 2 picks up five years after the first, with Joel (Pedro Pascal) and Ellie (Bella Ramsey). They endure new problems and encounter new individuals, including Abby (Kaitlyn Dever). There are many ...

The Trump administration announced a sweeping plan Thursday to restructure the Department of Health and Human Services by ...

In December 2015, then-presidential candidate Duterte put out a television ad that said, if bad guys don’t straighten up, “it’s your last merry Christmas.” Soriano had watched on the news the spate of ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Trastuzumab botidotin has met the primary endpoints of its pivotal Phase 2 trial for 3L+ advanced HER2+ BC based on results from the primary analysis, which the Company used to submit an NDA to the ...

Tensions ran high Monday as Maryland residents gathered at Greenwood Elementary School to air concerns over a drug rehab ...

Currently, terminally ill Montanans can obtain life-ending prescriptions under a legal loophole. One bill to ban the practice ...